Company / Total Assets
TENAX THERAPEUTICS, INC. Total Assets History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$104.2M
FY2025
5-year range
$23.3M / $104.2M
FY2021-FY2025
Trend
+7.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $23M to $104M over the past 9 years.
Based on SEC 10-K filings.
$104M in FY2025 with a 10-year CAGR of +1.1%.
Improved from $23M to $104M over the past 9 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +1.1%
Key checks
Key Insights
- In FY2025, total assets increased 7.8% year-over-year.
- Lowest total assets in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $104.2M | +7.8% |
| FY2024 | $96.7M | +314.2% |
| FY2016 | $23.3M | -75.0% |
| FY2015 | $93.4M | +0.0% |
| FY2014 | $93.4M | +2837.4% |
| FY2013 | $3.2M | -23.2% |
| FY2012 | $4.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026